In cancers, where a sustained energy supply and lipogenic signaling are essential for tumor growth and survival, DHA-induced restriction of energy influx, together with the downregulation of Pparγ, Fabp4, Fasn, Gpr120, and Slc2a4, disrupts key pro-tumorigenic pathways. The gene discussed is FFAR4; the disease is neoplasm.